Opaleye Management Inc.
Opaleye Management Inc., 10%, reported an open-market or private purchase at Grace Therapeutics, Inc. involving 7215.000000 shares for an estimated $14574.30. Reported holdings after the transaction were 2873289.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 12, 2026
- Filing date
- Oct 13, 2026
How reported position traded is calculated
Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 2,866,074 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
GRCE price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Buy Code P
- Identifier
- 0001493152-26-046899 Common Stock, par value $0.0001 per share
- Transaction date
- Oct 12, 2026 Filed Oct 13, 2026, 09:45 PM · 1d delay
- Shares
- 7,215 sh $2.02 per share
- Estimated value
- $14.5k Computed from shares × price
- Holdings after
- 2,873,289 sh Indirect · By Opaleye, L.P.
Filing signal explanations
Badges describe filing facts only — not predictions.
+28 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.
How this score is calculated
- open_market_purchase+12 points
transaction_code = P
Code P is a discretionary open-market purchase. - ten_percent_owner_buy+4 points
is_ten_percent_owner = true
10% beneficial owner open-market purchase. - repeat_buyer+8 points
repeat-buyer signal matched
Same insider bought again within the configured window. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management, Inc. may be deemed to beneficially own the securities owned directly by t…
- F2
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.03 to $2.05. The reporting person undertakes to provide, upon request by…
- F3
Opaleye Management, Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an…
0 other transactions
0 recent txs